Advertisement

Gerinnungsmanagement unter ECLS

  • Guido MichelsEmail author
  • Anton Sabashnikov
  • Julia Merkle
Chapter
  • 151 Downloads

Zusammenfassung

Innerhalb der letzten 50 Jahre wurden auf dem Gebiet des extrakorporalen Life Support Systems (ECLS) vor allem in Bezug auf die verwendeten Materialien und der angewandten Techniken große Fortschritte erzielt. Nichtsdestotrotz stellt das Gerinnungsmanagement unter ECLS immer noch eine besondere medizinische Herausforderung dar. Durch die ECLS-Therapie wird das normalerweise fein ausbalancierte Gerinnungssystem aufgrund der großen Exposition mit gerinnungsaktivierenden Fremdkörperoberflächen innerhalb des ECLS-Umlaufs massiv gestört.

Schlüsselwörter

Extrakorporale Membranoxygenierung Extrakorporeal Life Support Antikoagulation 

Literatur

  1. (Anonym) (2017) ELSO Guideline for Cardiopulmonary Extracorporal Support Extracorporal Life Support OrganizationExtracorporal Life Support Organization. Version 1.4Google Scholar
  2. Abrams D et al (2018) Position paper for the organization of ECMO programs for cardiac failure in adults. Intensive Care Med 44(6):717–729PubMedCrossRefGoogle Scholar
  3. Alexander DC et al (2010) Correlation of thromboelastography with standard tests of anticoagulation in paediatric patients receiving extracorporeal life support. Thromb Res 125(5):387–392PubMedCrossRefGoogle Scholar
  4. Annich GM (2015) Extracorporeal life support: the precarious balance of hemostasis. J Thromb Haemost 13(Suppl 1):S336–S342PubMedCrossRefGoogle Scholar
  5. Annich GM et al (2017) Thromboprophylaxis in extracorporeal circuits: current pharmacological strategies and future directions. Am J Cardiovasc Drugs 17(6):425–439PubMedCrossRefGoogle Scholar
  6. Anonym (2014) The Extracorporeal Life Support Organization (ELSO), Ann Arbor, MI, USA, ELSO Anticoagulation GuidelinesGoogle Scholar
  7. Anselmi A et al (2016) Safety of recombinant factor VIIa in patients under extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 49(1):78–84PubMedCrossRefGoogle Scholar
  8. Aranki SF et al (1993) Femoral veno-arterial extracorporeal life support with minimal or no heparin. Ann Thorac Surg 56(1):149–155PubMedCrossRefGoogle Scholar
  9. Bain J et al (2017) Heparin induced thrombocytopenia with mechanical circulatory support devices: review of the literature and management considerations. J Thromb Thrombolysis 44(1):76–87PubMedCrossRefGoogle Scholar
  10. Beckmann A et al (2011) Position article for the use of extracorporeal life support in adult patients. Eur J Cardiothorac Surg 40(3):676–680PubMedGoogle Scholar
  11. Bennett M et al (2018) The Safe Addition of Nitric Oxide into the Sweep Gas of the Extracorporeal Circuit during Cardiopulmonary Bypass and Extracorporeal Life Support. J Extra Corpor Technol 50(4):260–264PubMedPubMedCentralGoogle Scholar
  12. Bolliger D et al (2016) Point-of-care coagulation management algorithms during ECMO support: are we there yet? Minerva Anestesiol 82(9):1000–1009PubMedGoogle Scholar
  13. Bonar R, Favaloro EJ (2017) Explaining and reducing the variation in inter-laboratory reported values for International Normalised Ratio. Thromb Res 150:22–29PubMedCrossRefGoogle Scholar
  14. Broos K et al (2011) Platelets at work in primary hemostasis. Blood Rev 25(4):155–167PubMedCrossRefGoogle Scholar
  15. Byrnes J et al (2011) Hemolysis during cardiac extracorporeal membrane oxygenation: a case-control comparison of roller pumps and centrifugal pumps in a pediatric population. ASAIO J 57(5):456–461PubMedCrossRefGoogle Scholar
  16. Chan VH et al (2010) Novel paediatric anticoagulants: a review of the current literature. Blood Coagul Fibrinolysis 21(2):144–151PubMedCrossRefGoogle Scholar
  17. Choi JH et al (2019) Heparin-induced thrombocytopenia during extracorporeal life support: incidence, management and outcomes. Ann Cardiothorac Surg 8(1):19–31PubMedPubMedCentralCrossRefGoogle Scholar
  18. Coughlin MA, Bartlett RH (2015) Anticoagulation for Extracorporeal Life Support: Direct Thrombin Inhibitors and Heparin. ASAIO J 61(6):652–655PubMedCrossRefGoogle Scholar
  19. Cuker A (2014) Clinical and laboratory diagnosis of heparin-induced thrombocytopenia: an integrated approach. Semin Thromb Hemost 40(1):106–114PubMedGoogle Scholar
  20. Cuker A et al (2018) American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia. Blood Adv 2(22):3360–3392PubMedPubMedCentralCrossRefGoogle Scholar
  21. Dickey LA et al (1994) Selective heparinization of the extracorporeal membrane oxygenation circuit using continuous infusions of protamine and heparin in a short-term pig model. Perfusion 9(5):327–333PubMedCrossRefGoogle Scholar
  22. Diehl A, Gantner D (2018) Pump head thrombosis in extracorporeal membrane oxygenation (ECMO). Intensive Care Med 44(3):376–377PubMedCrossRefGoogle Scholar
  23. Downard CD et al (2003) Impact of AMICAR on hemorrhagic complications of ECMO: a ten-year review. J Pediatr Surg 38(8):1212–1216PubMedCrossRefGoogle Scholar
  24. Feindt P et al (2011) Use of extracorporeal circulation (ECC) outside the cardiac operating room: indications, requirements and recommendations for routine practice. Thorac Cardiovasc Surg 59(2):66–68PubMedCrossRefGoogle Scholar
  25. Gorlinger K et al (2012) Coagulation management in patients undergoing mechanical circulatory support. Best Pract Res Clin Anaesthesiol 26(2):179–198PubMedCrossRefGoogle Scholar
  26. Heilmann C et al (2012a) Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS). Intensive Care Med 38(1):62–68PubMedCrossRefGoogle Scholar
  27. Heilmann C et al (2012b) Established markers of renal and hepatic failure are not appropriate to predict mortality in the acute stage before extracorporeal life support implantation. Eur J Cardiothorac Surg 42(1):135–141 discussion 141PubMedCrossRefGoogle Scholar
  28. Jacobson J (2002) Nitric oxide: platelet protectant properties during cardiopulmonary bypass/ECMO. J Extra Corpor Technol 34(2):144–147PubMedGoogle Scholar
  29. Kalbhenn J et al (2018) Acquired von Willebrand syndrome and impaired platelet function during venovenous extracorporeal membrane oxygenation: Rapid onset and fast recovery. J Heart Lung Transplant 37(8):985–991PubMedCrossRefGoogle Scholar
  30. Karagiannidis C et al (2016) Extracorporeal membrane oxygenation: evolving epidemiology and mortality. Intensive Care Med 42(5):889–896PubMedCrossRefGoogle Scholar
  31. Kim YS et al (2018) Use of argatroban for extracorporeal life support in patients with nonheparin-induced thrombocytopenia: Analysis of 10 consecutive patients. Medicine (Baltimore) 97(47):e13235CrossRefGoogle Scholar
  32. Kimmoun A et al (2018) Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study. Intensive Care Med 44(9):1460–1469PubMedCrossRefGoogle Scholar
  33. Kulkarni T et al (2016) Extracorporeal membrane oxygenation in adults: a practical guide for internists. Cleve Clin J Med 83(5):373–384PubMedCrossRefGoogle Scholar
  34. Kumar TK et al (2010) Extracorporeal membrane oxygenation in postcardiotomy patients: factors influencing outcome. J Thorac Cardiovasc Surg 140(2):330–336, e332PubMedCrossRefGoogle Scholar
  35. Larsson M et al (2014) A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci Transl Med 6(222):222ra217CrossRefGoogle Scholar
  36. Le Gall A et al (2018) Veno-arterial-ECMO in the intensive care unit: From technical aspects to clinical practice. Anaesth Crit Care Pain Med 37(3):259–268PubMedCrossRefGoogle Scholar
  37. Levrat A et al (2008) Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. Br J Anaesth 100(6):792–797PubMedCrossRefGoogle Scholar
  38. Levy JH et al (2016) Antithrombin: anti-inflammatory properties and clinical applications. Thromb Haemost 115(4):712–728PubMedCrossRefGoogle Scholar
  39. Major TC et al (2014) Development and hemocompatibility testing of nitric oxide releasing polymers using a rabbit model of thrombogenicity. J Biomater Appl 29(4):479–501PubMedPubMedCentralCrossRefGoogle Scholar
  40. Makdisi G, Wang IW (2015) Extra Corporeal Membrane Oxygenation (ECMO) review of a lifesaving technology. J Thorac Dis 7(7):E166–E176PubMedPubMedCentralGoogle Scholar
  41. Mazzeffi M, Tanaka K (2016) Platelets and ECMO: should we worry about count, function, or both? Intensive Care Med 42(7):1199–1200PubMedCrossRefGoogle Scholar
  42. Meuwese CL et al (2018) Extracorporeal life support in cardiogenic shock: indications and management in current practice. Neth Heart J 26(2):58–66PubMedPubMedCentralCrossRefGoogle Scholar
  43. Niebler RA et al (2010) Activated recombinant factor VII for refractory bleeding during extracorporeal membrane oxygenation. Pediatr Crit Care Med 11(1):98–102PubMedCrossRefGoogle Scholar
  44. Novak M et al (2011) Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma. Blood Coagul Fibrinolysis 22(7):588–592PubMedCrossRefGoogle Scholar
  45. Palta S et al (2014) Overview of the coagulation system. Indian J Anaesth 58(5):515–523PubMedPubMedCentralCrossRefGoogle Scholar
  46. Peek GJ et al (2002) Early experience with a polymethyl pentene oxygenator for adult extracorporeal life support. ASAIO J 48(5):480–482PubMedCrossRefGoogle Scholar
  47. Pichler P et al (2015) Use of ECMO in adult patients with cardiogenic shock: a position paper of the Austrian Society of Cardiology. Med Klin Intensivmed Notfmed 110(6):407–420PubMedPubMedCentralCrossRefGoogle Scholar
  48. Pishko AM, Cuker A (2017) Heparin-Induced Thrombocytopenia in Cardiac Surgery Patients. Semin Thromb Hemost 43(7):691–698PubMedPubMedCentralCrossRefGoogle Scholar
  49. Pratt CW, Church FC (1991) Antithrombin: structure and function. Semin Hematol 28(1):3–9PubMedGoogle Scholar
  50. Repesse X et al (2013) Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review. Crit Care 17(2):R55PubMedPubMedCentralCrossRefGoogle Scholar
  51. Roberts TR et al (2019) Thromboelastography on-the-go: evaluation of the TEG 6s device during ground and high-altitude aeromedical evacuation with extracorporeal life support. J Trauma Acute Care Surg 87(1S):119–127CrossRefGoogle Scholar
  52. Saifee, NH et al (2019) Monitoring hemostasis during extracorporeal life support. ASAIO JGoogle Scholar
  53. Smith A et al (2013) Red blood cell transfusion volume and mortality among patients receiving extracorporeal membrane oxygenation. Perfusion 28(1):54–60PubMedCrossRefGoogle Scholar
  54. Thomas J et al (2018) Bleeding and thrombotic complications in the use of extracorporeal membrane oxygenation. Semin Thromb Hemost 44(1):20–29PubMedCrossRefGoogle Scholar
  55. Tory HO et al (2010) Outcomes of children treated for Lyme arthritis: results of a large pediatric cohort. J Rheumatol 37(5):1049–1055PubMedCrossRefGoogle Scholar
  56. van der Staak FH et al (1997) Surgical repair of congenital diaphragmatic hernia during extracorporeal membrane oxygenation: hemorrhagic complications and the effect of tranexamic acid. J Pediatr Surg 32(4):594–599PubMedCrossRefGoogle Scholar
  57. Weber C et al (2018) Left ventricular thrombus formation in patients undergoing femoral veno-arterial extracorporeal membrane oxygenation. Perfusion 33(4):283–288PubMedCrossRefGoogle Scholar
  58. Wikkelso A et al (2017) Thromboelastography (TEG) or rotational thromboelastometry (ROTEM) to monitor haemostatic treatment in bleeding patients: a systematic review with meta-analysis and trial sequential analysis. Anaesthesia 72(4):519–531PubMedCrossRefGoogle Scholar
  59. Zonies D, Merkel M (2016) Advanced extracorporeal therapy in Trauma. Curr Opin Crit Care 22(6):578–583PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature 2020

Authors and Affiliations

  • Guido Michels
    • 1
    Email author
  • Anton Sabashnikov
    • 2
  • Julia Merkle
    • 2
  1. 1.Klinik für Akut- und NotfallmedizinSt.-Antonius-Hospital gGmbH, Akademisches Lehrkrankenhaus der RWTH AachenEschweilerDeutschland
  2. 2.Klinik und Poliklinik für Herz- und ThoraxchirurgieUniklinik Köln, HerzzentrumKölnDeutschland

Personalised recommendations